This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Onyx Pharmaceuticals, Inc., Warner-Lambert Company. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Christian Ried: Innovator in Phosphoinositide Research
Introduction
Christian Ried is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biochemistry, particularly in the study of phosphoinositide 3-kinases (PI3K). His work has implications for understanding various cellular processes and potential therapeutic applications.
Latest Patents
Christian Ried holds a patent related to phosphoinositide 3-kinases. The patent encompasses PI3K crystals, polypeptide muteins, polypeptide fragments, antibodies, and nucleic acids coding for these polypeptides. It also details methods for modifying and modulating PI3Kγ activity. This invention includes polypeptides and methods related to phospholipid binding, lipid kinase activity, and the modulation of protein-protein interactions with PI3Kγ. He has 1 patent to his name.
Career Highlights
Throughout his career, Christian Ried has worked with prominent companies in the pharmaceutical industry. He has been associated with Warner-Lambert Company and Onyx Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in biochemistry and innovation.
Collaborations
Christian Ried has collaborated with notable professionals in his field, including Len Stephens and Roger Williams. These collaborations have likely enriched his research and development efforts.
Conclusion
Christian Ried is a distinguished inventor whose work in phosphoinositide 3-kinases has advanced our understanding of cellular mechanisms. His contributions continue to influence the field of biochemistry and hold promise for future innovations.